Can we use C-reactive protein levels to predict severe infection or sepsis in severely burned patients?

Marc G Jeschke1, Celeste C Finnerty, Gabriela A Kulp

  • 1Ross Tilley Burn Centre, Sunnybrook Health Sciences Centre, Sunnybrook Research Institute, Department of Surgery, Immunology and Plastic Surgery, University of Toronto Toronto, Canada.

Insights

C-reactive protein (CRP) does not predict severe infection or sepsis in pediatric burn patients. While CRP levels correlate with burn severity and survival, they are not a reliable indicator for infection risk in this population.

Area of Science:

  • Pediatric critical care
  • Burn injury management
  • Infectious disease diagnostics

Background:

  • Severe burns trigger a significant inflammatory response, often monitored using biomarkers like C-reactive protein (CRP).
  • Early identification of severe infections or sepsis is crucial for improving outcomes in pediatric burn patients.

Purpose of the Study:

  • To evaluate the predictive value of C-reactive protein (CRP) levels for severe infection or sepsis in pediatric burn patients.
  • To analyze the correlation between CRP levels, burn characteristics, and patient outcomes.

Main Methods:

  • A large cohort of 918 pediatric burn patients was analyzed.
  • C-reactive protein (CRP) levels were measured during hospitalization and up to 6 months postburn.
  • Demographic data, infection incidence, and clinical information were compiled; statistical analyses included ANOVA and regression.

Main Results:

  • CRP levels significantly correlated with burn size, survival, and gender.
  • Higher CRP levels were observed in patients with larger burns, non-survivors, and females (p<0.05).
  • Despite these correlations, CRP levels could not reliably predict severe infection or sepsis using established models.

Conclusions:

  • C-reactive protein (CRP) is an indicator of the inflammatory response following severe burns.
  • However, CRP levels are not a sufficient predictor of severe infection or sepsis in pediatric burn patients.
  • Further research may be needed to identify more accurate biomarkers for infection in this vulnerable population.

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Acute Inflammation II: Local and Systemic Effects01:25

Acute Inflammation II: Local and Systemic Effects

Acute inflammation produces a coordinated set of local and systemic changes that limit injury, eliminate pathogens, and initiate repair. These responses arise within minutes of infection, trauma, or chemical insult and are driven by vascular alterations and leukocyte-derived mediators. When the stimulus resolves, the reaction typically abates within days.Local EffectsAt the site of injury, arteriolar vasodilation increases blood flow, resulting in redness and warmth. Simultaneously, increased...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following: